Subthreshold α2-Adrenergic Activation Counteracts Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion
2011
How Clonidine Affects Insulin Secretion
Sample size: 10
publication
Evidence: moderate
Author Information
Author(s): Minglin Pan, Yang Guang, Cui Xiuli, Yang Shao-Nian
Primary Institution: Tianjin Medical University
Hypothesis
Does subthreshold α2-adrenergic activation interact with GLP-1 to regulate insulin secretion?
Conclusion
Subthreshold α2-adrenergic activation counteracts GLP-1's effect on insulin secretion.
Supporting Evidence
- Clonidine inhibits insulin secretion in a concentration-dependent manner.
- GLP-1 potentiates insulin secretion when glucose levels are elevated.
- Subthreshold clonidine can completely counteract the effects of GLP-1 on insulin secretion.
Takeaway
When the body needs to control insulin release, a small amount of clonidine can stop GLP-1 from helping insulin secretion.
Methodology
INS-1 cells were treated with glucose and either clonidine or GLP-1 to measure insulin secretion.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website